|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Brucella IgM ELISA | Amyloid Beta (1-42) ELISA Assay | Epstein-Barr Virus (EBNA-1) IgG ELISA | Glargine ELISA Assay | Leishmania infantum IgG ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB05019 | 27711 | IB79859 | IV2-113E | IB79808 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme linked immunosorbent assay (ELISA) for the determination of human IgM antibodies directed against pathogenic Brucella ssp. in serum and plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Aß(1-42) in cerebrospinal fluid, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay for the determination of IgG-class antibodies to Epstein-Barr virus nuclear antigen type 1 (EBV-EBNA-1) in human serum or plasma. For research use only - not for use in diagnostic procedures. | Immunometric assay (ELISA) for the determination of insulin Glargine in physiological plasma samples. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of antibodies against Leishmania infantum in human serum or plasma (citrate). For research use only, not for use in diagnostic procedures. |
| Detection Target | Brucella IgM | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) | SCC | Influenza Virus A IgG | Epstein-Barr Virus (EBNA-1) IgG |
| Sample Type | Serum and plasma (EDTA, citrate, heparin). | Serum and plasma. | Serum | Serum, Blood Plasma | Serum, Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 12.5 to 800 pg/mL | A cut-off control is used for the interpretation of results. | 10 to 250 mU/L. | Inquire |
| Sensitivity | > 92% | 1 ng/mL | Inquire | 98.55 % (95 % confidence interval: 92.19 % - 99.96 %) | 0.62 U/mL |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | Overnight + 1 hr 30 mins (incubation) | 1 hr 45 mins (incubation) | 6 hrs, 15 mins (incubation) | 1 hr 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |